Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Autor: Nyberg, Tommy, Ferguson, Neil M, Nash, Sophie G, Webster, Harriet H, Flaxman, Seth, Andrews, Nick, Hinsley, Wes, Lopez Bernal, Jamie, Kall, Meaghan, Bhatt, Samir, Blomquist, Paula, Zaidi, Asad, Volz, Erik, Abdul Aziz, Nurin, Harman, Katie, Funk, Sebastian, Abbott, Sam, Hope, Russell, Charlett, Andre, Chand, Meera, Ghani, Azra C, Seaman, Shaun R, Dabrera, Gavin, De Angelis, Daniela, Presanis, Anne M, Thelwall, Simon, Bernal, Jamie Lopez, Aziz, Nurin Abdul

Publikováno v: In The Lancet 2-8 April 2022 399(10332):1303-1312

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hospitalisation and mortality risk for COVID-19 cases with SARS-CoV-2 AY.4.2 (VUI-21OCT-01) compared to non-AY.4.2 Delta variant sub-lineages

Autor: Nyberg, Tommy, Harman, Katie, Zaidi, Asad, Seaman, Shaun, Andrews, Nick, Nash, Sophie G, Charlett, Andre, Lopez Bernal, Jamie, Myers, Richard, Groves, Natalie, Gallagher, Eileen, Gharbia, Saheer, Chand, Meera, Thelwall, Simon, De Angelis, Daniela, Dabrera, Gavin, Presanis, Anne

To investigate if the AY.4.2 sub-lineage of the SARS-CoV-2 Delta variant is associated with hospitalisation and mortality risks that differ from non-AY.4.2 Delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c11c75d97efae5c2f43b476bedac11

Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?

Autor: Brown AE; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.; These authors contributed equally to this work and share first authorship., Mohammed H; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.; These authors contributed equally to this work and share first authorship., Ogaz D; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Kirwan PD; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Yung M; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Nash SG; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Furegato M; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Hughes G; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Connor N; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Delpech VC; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom., Gill ON; HIV & STI Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2017 Jun 22; Vol. 22 (25).